An early steroidogenic defect in hormone-induced Leydig cell desensitization

Area of Science:

• Endocrinology and Reproductive Biology
• Mitochondrial Biochemistry
• Steroidogenesis

Background:

• Gonadotropin-induced desensitization in testicular Leydig cells affects early steroidogenesis.
• The precise molecular lesion in the initial steroidogenic pathway remains incompletely understood.

Purpose of the Study:

• To elucidate the nature of the defect in the early steroidogenic pathway of rat testicular Leydig cells following gonadotropin treatment.
• To identify the specific mechanism underlying hCG-induced desensitization concerning cholesterol metabolism.

Main Methods:

• Assessed cholesterol side-chain cleavage activity in isolated rat Leydig cell mitochondria via pregnenolone synthesis and radiolabeled cholesterol conversion.
• Utilized sonicated mitochondria and adrenal cell mitochondria as controls and enzyme sources.
• Characterized the inhibitory factor using biochemical techniques, including heat lability, size exclusion chromatography, and isoelectric focusing.

Main Results:

• hCG treatment reduced cholesterol side-chain cleavage activity in Leydig cell mitochondria, particularly at limiting NADPH concentrations.
• A heat-labile protein factor, identified in Leydig cell mitochondria, was found to increase with hCG treatment.
• This protein factor competitively inhibited cholesterol side-chain cleavage activity by altering the enzyme's affinity for NADPH (increased Km).

Conclusions:

• A mitochondrial inhibitory protein factor is present in normal Leydig cells and is activated by hCG.
• This factor contributes to the early steroidogenic lesion observed during gonadotropin desensitization.
• The protein may function as an endogenous modulator of steroid hormone biosynthesis.